Table 3 The difference of prognostic factors between PFS (−) group and PFS(+) group
Values | PFS (−) | PFS (+) | Statistic(χ2) | P-value |
|---|---|---|---|---|
N | 5 | 47 | ||
Platelet | 0.653 | 0.390 | ||
Increase | 1(20%) | 18(38.3%) | ||
Decrease | 4(80%) | 29(61.7%) | ||
D-dimer | 0.211 | 0.549 | ||
Increase | 1(20%) | 14(29.8%) | ||
Decrease | 4(80%) | 33(70.2%) | ||
Gender | 0.221 | 0.500 | ||
Male | 2(40%) | 24(51.1%) | ||
Female | 3(60%) | 23(48.9%) | ||
Age | 0.221 | 0.500 | ||
≥ 62.5 | 2(40%) | 24(51.1%) | ||
< 62.5 | 3(60%) | 23(48.9%) | ||
Smoking | 0.405 | 0.467 | ||
Past/current | 4(80%) | 31(66.0%) | ||
Never | 1(20%) | 16(34.0%) | ||
Exon21 | 2.038 | 0.153 | ||
No | 5(100%) | 33(70.2%) | ||
Yes | 0(0%) | 14(29.8%) | ||
Exon19 | 4.387 | 0.059 | ||
No | 5(100%) | 24(51.1%) | ||
Yes | 0(0%) | 23(48.9%) | ||
Other diseases | 3.457 | 0.077 | ||
No | 5(100%) | 27(57.4%) | ||
Yes | 0(0%) | 20(42.6%) | ||
Other treatment | ||||
No | 1(20%) | 19(40.4%) | 0.797 | 0.354 |
Yes | 4(80%) | 28(59.6%) |